Based on these literature data and on our results from the analysis of VEGFA mRNA expression in MR-transfected colon cancer cells grown under normoxic conditions upon activation by the relative agonists, we suggest that MR may inhibit deregulated angiogenesis in CRC. The gene discussed is NR3C2; the disease is malignant colon neoplasm.